BioGenerator Ventures is a major player in St. Louis’ bioscience industry
It is the investment arm of the bio-sciences ecosystem nonprofit known as BioSTL.
BioGenerator Ventures, the investment arm of the bio-sciences ecosystem nonprofit BioSTL, is a major player in St. Louis’ bioscience industry.
Its companies have received more than $2.7 billion in capital from more than 250 venture capital and private equity sources, which represents 60:1 leverage on the $44 million that BioGenerator has invested—and 85 percent of the outside capital has come from outside St. Louis. There have been several successful exits, too—Confluence Life Sciences and CoverCress, for example, have both been acquired by larger companies—and more exits are likely on the way.
James McCarter, the new head of BioGenerator, says, “Nearly half of our investment opportunities are coming out of WashU (Washington University in St. Louis), yet we are not well known there,” he says. “We’re going to change that.”
A major player in St. Louis’ bioscience industry, McCarter assumed his role in October and is planning a storytelling blitz for 2025. Whether it’s speeches, podcasts, videos, newsletters, social media, or panel discussions, McCarter wants to “vastly increase” his group’s visibility.
Want to know the plan? Click on this article from St. Louis Magazine.
Like what you've read?
Forward to a friend!